Vertex Pharmaceuticals Sets $3 Billion Share Repurchase Program
2023年2月8日 - 6:37AM
Dow Jones News
By Kathryn Hardison
Vertex Pharmaceuticals Inc.'s board of directors has approved a
new share repurchase program for up to $3 billion of common
stock.
The program doesn't have an expiration date and can be
discontinued at any time, the company said Tuesday.
The board approved the new program on Feb. 1.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
February 07, 2023 16:22 ET (21:22 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2024 まで 8 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 8 2023 まで 8 2024